Video
Three-Year Outcomes of the Randomized SCOPE I Trial Comparing the ACURATE Neo Versus the SAPIEN 3 Transcatheter Heart Valve System in Patients With Symptomatic Severe Aortic Stenosis
04:57
Yazan Daaboul and Jonas Lanz discuss Three-Year Outcomes of the Randomized SCOPE I Trial at TCT 2022
